https://zyduspharma.ca/milestones/pre-2000/ 2026-04-09T10:37:09+00:00 https://zyduspharma.ca/milestones/pre-2001/ 2026-04-09T10:37:13+00:00 https://zyduspharma.ca/milestones/pre-2002/ 2026-04-09T10:37:18+00:00 https://zyduspharma.ca/milestones/1995-1996-acquired-indo-pharma-pharmaceutical-works-ltd-the-groups-first-acquisition/ 2026-04-09T10:37:21+00:00 https://zyduspharma.ca/milestones/1995-1996-launched-23-new-products-in-1995-with-first-in-india-like-falcigo/ 2026-04-09T10:37:24+00:00 https://zyduspharma.ca/milestones/1995-1996-zyduss-journey-began-with-rs-250-crs/ 2026-04-09T10:37:27+00:00 https://zyduspharma.ca/milestones/1997-1998-entered-into-jv-with-byk-gulden-a-german-pharma-major-to-set-up-a-5050-jv/ 2026-04-09T10:37:32+00:00 https://zyduspharma.ca/milestones/1999-2000-entered-into-capital-markets-through-initial-public-offering-ipo/ 2026-04-09T10:37:37+00:00 https://zyduspharma.ca/milestones/1999-2000-entered-into-jv-with-sarabhai-for-consolidating-its-position-in-animal-healthcare/ 2026-04-09T10:37:41+00:00 https://zyduspharma.ca/milestones/2000-2001-acquired-recon-healthcare-which-boosted-zyduss-strengths-in-southern-markets/ 2026-04-09T10:37:46+00:00 https://zyduspharma.ca/milestones/2000-2001-zydus-research-centre-set-up-at-moraiya/ 2026-04-09T10:37:50+00:00 https://zyduspharma.ca/milestones/2000-2002-acquired-german-remedies-the-largest-ma-in-the-indian-pharmaceutical-sector-at-the-time/ 2026-04-09T10:37:53+00:00 https://zyduspharma.ca/milestones/2001-2002-acquired-aten-and-attained-the-top-spot-in-the-cardiovascular-segment-in-india/ 2026-04-09T10:42:26+00:00 https://zyduspharma.ca/milestones/2005-2006-acquired-30-7-stake-in-carnation-nutra-analogue-foods-ltd/ 2026-04-09T10:43:01+00:00 https://zyduspharma.ca/milestones/2006-2007-acquired-liva-healthcare-and-entered-the-dermatology-market-in-india/ 2026-04-09T10:43:08+00:00 https://zyduspharma.ca/milestones/2006-2007-acquired-nippon-universal-and-entered-the-japanese-market/ 2026-04-09T10:43:17+00:00 https://zyduspharma.ca/milestones/2008-2009-acquired-laboratorios-combix-in-spain-simayla-pharma-in-south-america-and-etna-biotech-in-italy/ 2026-04-09T10:43:27+00:00 https://zyduspharma.ca/milestones/2009-2010-launched-first-formulation-using-nano-technology-platform-in-india-oxalgin-nanogel/ 2026-04-09T10:43:32+00:00 https://zyduspharma.ca/milestones/2010-2011-achieved-1-billion-in-sales/ 2026-04-09T10:46:01+00:00 https://zyduspharma.ca/milestones/2010-2011-entered-into-a-5050-jv-with-bayer-to-set-up-a-new-marketing-company/ 2026-04-09T10:49:34+00:00 https://zyduspharma.ca/milestones/2010-2011-entered-into-strategic-agreement-with-abbott-for-commercializing-branded-generics-in-emerging-markets/ 2026-04-09T10:51:00+00:00 https://zyduspharma.ca/milestones/2010-2011-launched-vaxiflu-s-indias-first-h1n1-vaccine/ 2026-04-09T10:51:46+00:00 https://zyduspharma.ca/milestones/2011-2012-acquired-bremer-pharma-gmbh-to-gain-a-global-footprint-in-the-animal-healthcare-business/ 2026-04-09T10:52:39+00:00 https://zyduspharma.ca/milestones/2012-2013-over-114-new-products-launched-during-the-year-31-of-which-were-first-in-india-launches/ 2026-04-09T10:54:27+00:00 https://zyduspharma.ca/milestones/2013-received-usfda-approval-for-initiating-phase-i-clinical-trials-of-zydpla1-a-novel-next-generation-orally-active-small-molecule-dpp-4-inhibitor-to-treat-type-2-diabetes/ 2026-04-09T10:55:02+00:00 https://zyduspharma.ca/milestones/2014-zydus-launched-worlds-first-biosimilar-of-adalimumab/ 2026-04-09T10:55:29+00:00 https://zyduspharma.ca/milestones/2015-zydus-began-phase-iii-study-of-saroglitazar-in-nash/ 2026-04-09T10:55:57+00:00 https://zyduspharma.ca/milestones/2016-zydus-acquired-zoetis-a-global-animal-health-company/ 2026-04-09T10:56:26+00:00 https://zyduspharma.ca/milestones/2016-zydus-and-takeda-entered-into-partnership-to-address-emerging-infection-diseases/ 2026-04-09T10:56:55+00:00 https://zyduspharma.ca/milestones/2016-zydus-received-approval-from-the-usfda-to-initiate-phase-ii-clinical-trials-of-saroglitazar-in-patients-with-non-alcoholic-steatohepatitis-nash-of-the-liver-in-the-us/ 2026-04-09T10:57:57+00:00 https://zyduspharma.ca/milestones/2017-zydus-received-usfda-approval-to-initiate-phase-ii-clinical-studies-of-saroglitazar-in-patients-with-primary-biliary-cholangitis-pbc/ 2026-04-09T11:00:30+00:00 https://zyduspharma.ca/milestones/2017-zydus-started-phase-ii-trial-of-zyan1-for-treating-anemia-in-patients-with-ckd/ 2026-04-09T11:00:57+00:00 https://zyduspharma.ca/milestones/2018-zydus-partnered-with-medicure-to-launch-its-nda-product-zypitamag/ 2026-04-09T11:02:04+00:00 https://zyduspharma.ca/milestones/2019-zydus-wellness-ltd-completed-the-acquisition-of-heinz-india-private-limited/ 2026-04-09T11:03:00+00:00 https://zyduspharma.ca/milestones/2020-cadila-healthcare-ltd-received-usfda-approval-to-initiate-clinical-trials-of-desidustat-in-chemotherapy-induced-anemia-cia/ 2026-04-09T11:04:15+00:00 https://zyduspharma.ca/milestones/2020-zydus-granted-fast-track-designation-by-usfda-for-saroglitazar-mg-in-the-treatment-of-patients-with-primary-biliary-cholangitis-pbc/ 2026-04-09T11:04:40+00:00 https://zyduspharma.ca/milestones/2021-zydus-granted-orphan-drug-designation-by-the-usfda-for-saroglitazar-mg-in-the-treatment-of-patients-with-primary-biliary-cholangitis-pbc/ 2026-04-09T11:05:09+00:00 https://zyduspharma.ca/milestones/2001-2002-acquired-usfda-approved-api-plant-banyan-chemicals/ 2026-04-09T11:10:41+00:00 https://zyduspharma.ca/milestones/2002-2003-zydus-pharmaceuticals-usa-inc-incorporated/ 2026-04-09T11:12:05+00:00 https://zyduspharma.ca/milestones/2003-2004-acquired-alpharma-france-renamed-zydus-france-zyduss-first-international-acquisition/ 2026-04-09T11:13:41+00:00 https://zyduspharma.ca/milestones/2004-2005-filed-first-ind-in-india-for-zyh11/ 2026-04-09T11:14:43+00:00 https://zyduspharma.ca/milestones/2007-2008-entered-into-branded-generic-market-of-brazil-with-the-acquisition-of-quimica-e-farmaceutica-nikkho-do-brasil-ltda/ 2026-04-09T11:15:42+00:00 https://zyduspharma.ca/milestones/2011-2012-acquired-100-stake-in-biochem-one-of-the-top-40-pharma-companies-in-india/ 2026-04-09T11:16:40+00:00 https://zyduspharma.ca/milestones/2011-2012-acquired-the-assets-of-us-based-nesher-pharmaceuticals-inc/ 2026-04-09T11:18:05+00:00 https://zyduspharma.ca/milestones/2011-2012-received-usfda-approval-of-baddi-manufacturing-plant/ 2026-04-09T11:18:48+00:00 https://zyduspharma.ca/milestones/2016-zydus-began-supplying-product-in-the-us-market-from-its-sez-facility/ 2026-04-09T11:19:43+00:00 https://zyduspharma.ca/milestones/2016-zyduss-nesher-pharmaceuticals-received-its-first-anda-approval-dextroamphetamine-tablets/ 2026-04-09T11:20:35+00:00 https://zyduspharma.ca/milestones/2017-zydus-cadila-acquired-sentynl-therapeutics-inc-us-based-specialty-company/ 2026-04-09T11:21:29+00:00 https://zyduspharma.ca/milestones/2017-zydus-launched-indias-first-tetravalent-inactivated-influenza-vaccine-vaxiflu-4/ 2026-04-09T11:22:11+00:00 https://zyduspharma.ca/milestones/2017-zydus-received-regulatory-approval-of-lipaglyntm-in-mexico/ 2026-04-09T11:22:47+00:00 https://zyduspharma.ca/milestones/2018-cadila-healthcare-acquired-51-stake-in-windlas-healthcare/ 2026-04-09T11:23:31+00:00 https://zyduspharma.ca/milestones/2019-zydus-received-usfda-approval-for-its-first-transdermal-product-rivastigmine-transdermal-system/ 2026-04-09T11:24:26+00:00 https://zyduspharma.ca/milestones/2020-zydus-began-supplying-product-in-the-us-market-from-its-liva-facility/ 2026-04-09T11:25:54+00:00 https://zyduspharma.ca/milestones/2021-zydus-cadilas-zycov-d-vaccine-the-first-plasmid-dna-vaccine-to-be-approved-for-human-use-in-the-world-was-granted-emergency-use-authorization-in-india-for-adults-and-children/ 2026-04-09T11:26:41+00:00 https://zyduspharma.ca/milestones/2022-cadila-healthcare-limited-rebranded-to-zydus-lifesciences-limited-the-companys-new-brand-identity-brings-together-two-hearts-in-purple-and-teal-colors-symbolizing-its-commitme/ 2026-04-09T11:27:24+00:00